Overnight, ORSA provided an update about its response to CDA’s reimbursement recommendation for Daybue in Canada. Sorry I can’t post the link.
I might ask Jon a question about this if we have an earnings call investor webinar next week, although the US analysts will likely beat me to it and ask the same of Acadia management in their earnings call beforehand.
I have been wondering if the trade tensions between the US and Canada are a contributing factor in CDA’s draft decision or if it was just the opening salvo in price negotiations as others have mentioned.
Overnight, ORSA provided an update about its response to CDA’s...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.85 |
Change
-0.110(0.85%) |
Mkt cap ! $1.598B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $6.559M | 511.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1657 | $12.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.85 | 6303 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |